news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

in-hospital preparations have brought new hope to the traditional chinese medicine industry.

on september 9, the henan provincial medical insurance bureau issued a notice stating that starting from september 10,188 qualified medical institutions' preparations will be included in the province's medical insurance payment scope, and determined a unified payment standard for the whole province. at the same time, adjustments were made to 91 medical institution preparations or payment standards in the "catalog", and aner shen granules and sanjia yigan granules were removed from the "catalog".

the 188 types of in-hospital preparations approved by the henan medical insurance bureau for inclusion in the medical insurance are all chinese patent medicines.the "notice" clearly states that these preparations are managed as class b drugs and implement the treatment policies of each coordinated region.

in july this year, the guangxi medical insurance bureau added 37 new therapeutic hospital preparations to the medical insurance list, all of which are also traditional chinese medicines.

traditional chinese medicine is being squeezed by centralized procurement and rising raw material prices, but the large-scale addition of in-hospital preparations to local medical insurance has left a glimmer of hope. in fact, since 2013, beijing, shanghai, zhejiang, shandong, sichuan, hunan and other places have successively included local in-hospital preparations in the scope of local medical insurance reimbursement.there are tens of thousands of types of in-hospital preparations involved.

in-hospital preparations may be the next driving force for the development of the traditional chinese medicine industry.

many places have published articles

in-hospital preparations included in reimbursement

in just a few months, many provinces have issued documents requiring the inclusion of in-hospital preparations in the medical insurance catalogue, which will not only provide more treatment options for patients, but also allow the traditional chinese medicine industry to see another development path.

according to the notification requirements of henan province,in principle, the use of in-hospital preparations of medical institutions is limited to the medical institutions themselves.the provincial drug supervision and administration department has approved the use of medical institution preparations, and the cost of the drugs used can be included in the payment scope of the corresponding fund after the approval of the provincial medical insurance or provincial human resources and social security department. this means that if these in-hospital preparations are used outside the designated hospitals, patients need to pay for them themselves.

taking xianhao rupixiao oral liquid as an example, the medical institution that reimburses according to regulations is the first affiliated hospital of henan university of traditional chinese medicine, and the medical insurance payment standard is 66.2 yuan per box.

compared with henan, guangxi has much looser reimbursement requirements for in-hospital preparations.in addition to the need to be configured for use in designated medical institutions, medical institution preparations prepared by each member unit within a close-knit medical alliance can be adjusted and used within the medical alliance.

local medical insurance has long stopped allowing additional reimbursement of drugs, except for in-hospital preparations. henan believes that adding 188 in-hospital preparations of traditional chinese medicine is to implement the country's strategic deployment on promoting the inheritance and innovative development of traditional chinese medicine. but in fact,in-hospital preparations are prepared by the hospitals themselves and their sales are reimbursed by medical insurance. this is actually a way to increase hospital income and squeeze out external chinese patent medicines.

in addition to in-hospital preparations, jiangxi, shaanxi, shandong, anhui and other places have included chinese medicine formula granules in the medical insurance catalogue. most of these formula granules are products of local enterprises, which actually means "keeping the benefits within the family" and poses competition to other chinese patent medicines.

market expansion is imminent

or a new force in the innovation of traditional chinese medicine

the chinese medicine industry has temporarily fallen into a trough due to policy influence. according to wind data,in the first half of 2024, among the 72 listed companies in the a-share traditional chinese medicine sector, the operating income of 50 companies decreased year-on-year.it is generally believed in the industry that this is due to the influence of many factors such as production costs and product aging, and the vitality of the traditional chinese medicine industry urgently needs a shot in the arm.

in march this year, the national health insurance administration responded to the "letter on the reply to proposal no. 03662 (medical and health category no. 328) of the first session of the 14th national committee of the chinese people's political consultative conference", which mentioned that provincial health insurance departments should adjust their powers and procedures according to national regulations.qualified ethnic medicines, medical institution preparations and chinese herbal medicine slices can be included in the provincial medical insurance payment scope, and implemented after filing in accordance with regulations.

this policy has boosted the enthusiasm of various provinces to include in-hospital preparations. the market for in-hospital preparations and formula granules of traditional chinese medicine is expected to expand further, which is beneficial to the entire traditional chinese medicine industry.it is not ruled out that pharmaceutical companies will acquire in-hospital preparations in the future.after all, in-hospital preparations themselves are an important force in the innovation of traditional chinese medicine.

according to authoritative data,the market size of in-hospital preparations in various provinces and cities has reached hundreds of millions of yuan, while the market size of chinese medicine formula granules is close to 30 billion yuan.it is generally believed in the industry that with the relaxation of medical insurance reimbursement policies and the expansion of product market share, the sales volume of the traditional chinese medicine industry will increase rapidly in the future.

innovation in traditional chinese medicine is the focus of the development of china's pharmaceutical industry. it is generally believed in the industry that, with the support of favorable policies and positive stimulation from the external environment, the traditional chinese medicine industry is accelerating the integration of inheritance and innovation, and innovation in traditional chinese medicine is gradually ushering in a harvest period.

backstage replyhenan

get the full directory list

written by lei gong

editor: jiang yunjiating

operation｜valley

illustration｜visual china

disclaimer: this is original content from jianshiju. please do not reprint without permission.

abbvie is anxious! suing beigene

innovative pharmaceutical company announces: drastically reducing business in china and further layoffs

new news | if you have expired medicines at home, you can participate in the "expired medicine recycling program"